Pharmaceutical Chemistry Journal

, Volume 35, Issue 4, pp 179–182 | Cite as

Drugs for the Treatment of Alzheimer's Disease

  • M. D. Mashkovskii
  • R. G. Glushkov
Article

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    I. V. Damulin, Zh. Nevral. Psikhiatr., No. 12, 56–60 (1998).Google Scholar
  2. 2.
    Goodman and Gilman's The Pharmacological Basis of Therapy, 9th ed., MaGraw-Hill, New York (1996), pp. 513–514.Google Scholar
  3. 3.
    R. T. Bartus and R. Y. Dean, Science, 217, 408–417 (1980).Google Scholar
  4. 4.
    F. T. Coyle, D. L. Price, and M. R. Delong, Science, 219, 1184–1190 (1983).Google Scholar
  5. 5.
    É. F. Lavretskaya and L. M. Sarkisyants, Khim.-Farm. Zh., 16(2), 249–251 (1982).Google Scholar
  6. 6.
    G. N. Ponomareva and T. V. Sitnik, Ekspress-Inform. Novye Lek. Prep., No. 2, 11–14 (1990).Google Scholar
  7. 7.
    I. F. Roshchina, I. V. Kol'khalov, I. D. Selezneva, et al., Zh. Nevral. Psikhiatr., No. 12, 43–46 (1999).Google Scholar
  8. 8.
    M. D. Mashkovskii and R. P. Kruglikova-L'vova, Farmakol. Toksikol, No. 6, 27–32 (1951).Google Scholar
  9. 9.
    T. Thomson and U. Bickel, Dementia, No. 1, 46–51 (1990).Google Scholar
  10. 10.
    U. Gina, A. Bores, W. Raymond, and Fr. Kosley, Drugs Future, No. 6, 623–635 (1998).Google Scholar

Copyright information

© Plenum Publishing Corporation 2001

Authors and Affiliations

  • M. D. Mashkovskii
    • 1
  • R. G. Glushkov
    • 1
  1. 1.Center for Drug ChemistryAll-Russia Research Institute of Pharmaceutical Chemistry,Moscow,Russia.

Personalised recommendations